Team Health Holdings (TMH) Reports In-Line Q3 EPS, Sales Top Expectations
Tweet
Share
E-mailGet Alerts TMH Hot Sheet
Join SI Premium – FREE
Team Health Holdings (NYSE: TMH) reported Q3 EPS of $0.30, in-line with the analyst estimate of $0.30. Revenue for the quarter came in at $443.6 million versus the consensus estimate of $430.92 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
